6 Top Performing Technology Stocks That Can't Be Ignored

With innovations happening at the blink of an eye, it can be daunting to keep up with the latest tech trends. These are the hottest technology stocks at the moment, make sure you don't miss out!

By clicking the link above you will automatically opt-in to receive emails from FinStrategist

SAGE
Sage Therapeutics, Inc
NASDAQ
12.06
Open 11.7 Prev Close 11.18
High 11.75 Low 11.00
Volume 3,913,557 Volume (Avg) 1,079,072
52 Week High 98.39 52 Week Low 25.25
Market Cap 4.4B PE Ratio -1.34

Shares Stats

Shares Outstanding58,381,900
Shares Float51,182,273
Shares Short5,201,650
Insider Holdings161%
Institution Holdings93.80%

About Sage Therapeutics, Inc

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, bipolar depression, and generalized anxiety disorders; and SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases. In addition, its product pipeline comprises SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which has completed Phase I clinical trial for the treatment of depression, Huntington's disease, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. Sage Therapeutics, Inc. has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

General

NameSage Therapeutics, Inc
TickerSAGE
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees298

Highlights

Analyst Target102.21
Market Cap4,382,729,216
PE Ratio-1.34
PEG Ratio0.74
EBITDA626,598,976

Financials

Curr Year EPS Estimate-7.73
Next Quarter EPS Estimate0.75
Profit Margin0.54
Return on Assets0.24
Return on Equity0.40
Revenue1,114,200,064
Earnings Per Share11.43
Revenue Per Share21.43
Gross Profit820,921,000
Quarterly Revenue Growth564.91

Valuation

Trailing PE6.57
Price/Sales (Trailing 12 Mt.)3.76
Price/Book (Most Recent Quarter)2.23

Earnings

Most Popular

Crypto Millionaires Names His Favorite AI Coin - Ad

According to Bitcoin pioneer and crypto millionaire Charlie Shrem, a tiny $11 project could be the biggest winner of not just the next year, but the next decade. It combines AI and crypto, in one investment.

Citius Pharma's 'Antibiotic Lock' Effective In Patients With Catheter-Associated Bloodstream Infections

Citius Pharmaceuticals' Phase 3 trial results for Mino-Lok, an antibiotic lock solution for central line-associated infections, show significant improvement in time to catheter failure and overall treatment success.

"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." - Ad

The former Goldman Sachs VP -- who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio -- is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."

EU reprimands Kosovo's move to close Serb bank branches over the use of the dinar currency

PRISTINA, Kosovo (AP) — The European Union on Tuesday reprimanded Kosovo over the unilateral closure of six branches of , saying the move would negatively impact the life of the ethnic Serb minority living in northern Kosovo and damage Kosovo-Serbia normalization talks.

Should You Buy Bitcoin in 2024? [Expert's Shocking Answer] - Ad

Bitcoin minted 100,000 millionaires and if you're not one of them, that ship has sailed. But there's another millionaire-minting crypto at our doorstep... research shows this coin could be 20X bigger than Bitcoin by the end of the decade. With crypto starting to heat up again, this could be the perfect time to get in.

China's EV Maker XPeng Speeds Ahead with Strong Revenue Growth, Expects Selling More Than 29K Units In Q2

XPeng Inc reported a 62.3% sales growth in Q1 2024 but missed analyst estimates. Vehicle deliveries increased 19.7% and gross margin improved.

'Star Wars' Actor Mark Hamill Makes Surprise White House Appearance, Coins Biden 'Joe-B-Wan Kenobi'

Mark Hamill gave President Biden a Star Wars-inspired nickname, Joe-B-Wan Kenobi, adding pop culture touch to political landscape.

Buy This Next Gen Crypto Before Its Big Upgrade - Ad

Experts predict this one crypto will soar 7,200% by the end of the decade... and grow 20X bigger than bitcoin. But you must get in before it's big.

One natural gas transport plan killed in New Jersey as another forges ahead

KEYPORT, N.J. (AP) — A major pipeline that would have moved natural gas through New Jersey and under two bays to New York has been killed, but another plan to transport liquefied gas from Pennsylvania by tanker truck is moving forward.

Australia Calls For Inquiry Into Meta's Facebook, Elon Musk's X, TikTok To 'Make These Platforms Accountable For Their Decisions'

The Australian government has expressed concerns over the lack of regulation and oversight on social media platforms, which have a significant impact on the content viewed by Australians. The inquiry will specifically focus on the platforms' handling of violent content and their withdrawal from paying for news in Australia.

AI & Crypto in One $11 Investment - Ad

Right now, you can harness the power of two bull markets... Artificial intelligence and cryptos...In one simple $11 investment.

James Simons, mathematician, philanthropist and hedge fund founder, has died

James “Jim” Simons, a renowned mathematician and pioneering investor who built a fortune on Wall Street and then became one of the nation's biggest philanthropists, has died at age 86.

Defi Coin Triggers All "Buy" Signals and Could Break Out Soon - Ad

Some are calling this the most promising DeFi project since Ethereum itself. Here's the #1 DeFi Coin Set to Soar. While Bitcoin grabs headlines, this lesser known DeFi coin is quietly gearing up for a monster rally. Experts say now is the time to buy before it reaches escape velocity.

Embed-Chart-Off The Charts-Low-Income-Squeeze, ADVISORY

OFF THE CHARTS-LOW-INCOME-SQUEEZE — Chart. Overall spending by U.S. consumers remains healthy, but weakness at the bottom end of the income spectrum could be a warning signal of more pressure to come. This chart is current as of 05 10, 2024 and will not update. Source: FactSet. Click for a .

Germany recalls its ambassador in Russia for a week in protest over a hacker attack

BERLIN (AP) — Germany said Monday it recalled its ambassador to Russia for a week of consultations in Berlin following an alleged hacker attack on Chancellor Olaf Scholz’s party.

BREAKING: New "Formula" Could Lead to Huge AI Payouts - Ad

Investors - including multiple billionaires - are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash.

Buffett Says No Other Americans Would Have Had To Pay Even A Dime In Federal Taxes If This Had Happened

Warren Buffett suggests that federal taxes will likely increase given the country's precarious fiscal position, and he expressed Berkshire's willingness to cover the tax bill it faces.

Virgin Galactic Reports Better-Than-Expected Q1 Results

Virgin Galactic reported quarterly losses of 25 cents per share which beat the analyst consensus estimate of losses of 29 cents by 13.79%.

Could Elon Musk's New Device Save Us from A.I. Apocalypse? - Ad

A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. So he invented this strange new device to protect us against that A.I. threat. See this strange device you could be wearing some day.

Uranium Prices Soar 74% in 6 Months! The Uranium Bull Market Is Here to Stay! - Ad

In December 2023, 22 countries pledged to 3X their nuclear capacity. Sending these uranium stocks into a frenzy. Here's 1 uranium miner that exploration records show is sitting on 2.4 million pounds of uranium.

Federal Judge Indefinitely Postpones Donald Trump's Classified Documents Trial

The trial of ex-President Donald Trump for retaining classified documents has been postponed indefinitely by a federal judge.

The Mysterious Tale of "America's No. 1 Retirement Stock" - Ad

This factory of 53,000 employees, in Burbank, CA, was camouflaged to look like a sleepy suburb (with the help of artists, set designers, and painters from nearby Hollywood movie studios). The mysterious company behind this disappearing act is now being called "America's No. 1 Retirement Stock".

Electric Company PPL Powers Past Q1 Estimates, Eyes Bright Future

PPL Corporation beat revenue and EPS consensus in Q1 FY24, with Y/Y growth in electricity sales. Outlook and dividend growth reaffirmed.

Hope Hicks Testifies On Trump's Ex-Lawyer Michael Cohen's 'Mr. Fix It' Moniker: 'Only Because He Broke It First'

The criminal trial against Donald Trump saw former Trump aide Hope Hicks take the stand Friday and discuss Michael Cohen and the "Access Hollywood" tape.

Forget Gold. Ditch AI Stocks. Get In on This Instead - Ad

If you're nowhere near the place you want to be with your retirement savings right now and worried about what the future has in store... you owe it to yourself to give me just 10 minutes of your time today... Do that and you'll discover the jaw-dropping details we've uncovered about the next generation of investing.

Nvidia's AI Dominance Evident As Tech Behemoths From Microsoft To Meta And Google Keep Pumping Billions Into Chipmaker, Analysis Reveals

Nvidia is set to release its first-quarter earnings, and the company is already making waves in the AI sector. The tech giant's AI infrastructure is in high demand, as evidenced by the increased capital expenditures of its major clients.

Discover "U.S.'s New Money" Before Biden Wins - Ad

A new form of money has emerged in America, and it's making some folks wildly rich... (Musk and Bezos both use it). Find out how you can too in this free video.

I-95 overpass in Connecticut scorched during a fuel truck inferno has been demolished

NORWALK, Conn. (AP) — A bridge damaged in a fiery crash that kept Interstate 95 in Connecticut has been demolished.

One Tech Tip: Protecting your car from the growing risk of keyless vehicle thefts

LONDON (AP) — They appear like ghosts in the night, standing outside your house, one holding up an antenna while the other crouches next to the car parked on the driveway. Within seconds, your car is gone, yet another victim amid enabled by the technology designed to make it easier to unlock and start vehicles.

Mystery of the Rich and Connected Revealed - Ad

Former Goldman VP reveals a mysterious "Gold Bank" with huge upside potential... Last time we shared this, some folks could have seen a 995% gain. Don't be surprised if you've never heard of this -- most haven't. But he's sharing all in this new video.

'Dogecoin Killer' Shiba Inu Burn Rate Spikes 800%, Crypto Market Rallies As Sentiment Soars And More: This Week In Cryptocurrency

The week was a rollercoaster ride for the cryptocurrency market. The crypto world was buzzing with news, from Shiba Inu’s surging burn rate to speculation of certain altcoins becoming irrelevant.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service